| Attribute |
Value |
| 52 Week Change |
-0.7912042 |
| Address1 |
Friedrich-Ebert-Anlage 35-37 |
| All Time High |
55.65 |
| All Time Low |
5.18 |
| Ask |
11.31 |
| Ask Size |
2 |
| Average Daily Volume10 Day |
47,000 |
| Average Daily Volume3 Month |
36,263 |
| Average Volume |
36,263 |
| Average Volume10Days |
47,000 |
| Bid |
16.15 |
| Bid Size |
5 |
| Book Value |
0.687 |
| City |
Frankfurt am Main |
| Compensation As Of Epoch Date |
1,735,603,200 |
| Country |
Germany |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
9.51 |
| Current Ratio |
344.311 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
9.78 |
| Day Low |
9.0 |
| Earnings Timestamp End |
1,745,837,940 |
| Earnings Timestamp Start |
1,745,837,940 |
| Ebitda Margins |
0.0 |
| Enterprise To Revenue |
46.896 |
| Enterprise Value |
405,504,096 |
| Eps Trailing Twelve Months |
0.14 |
| Esg Populated |
0 |
| Exchange |
NGM |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
21.9447 |
| Fifty Day Average Change |
-12.4347 |
| Fifty Day Average Change Percent |
-0.56663793 |
| Fifty Two Week Change Percent |
-79.12042 |
| Fifty Two Week High |
55.65 |
| Fifty Two Week High Change |
-46.14 |
| Fifty Two Week High Change Percent |
-0.8291105 |
| Fifty Two Week Low |
8.3 |
| Fifty Two Week Low Change |
1.21 |
| Fifty Two Week Low Change Percent |
0.14578313 |
| Fifty Two Week Range |
8.3 - 55.65 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,739,975,400,000 |
| Float Shares |
39,691,251 |
| Free Cashflow |
-9,605,703 |
| Full Exchange Name |
NasdaqGM |
| Full Time Employees |
27 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.87236 |
| Gross Profits |
7,543,162 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.047849998 |
| Held Percent Institutions |
0.04899 |
| Implied Shares Outstanding |
43,891,200 |
| Industry |
Medical Instruments & Supplies |
| Industry Disp |
Medical Instruments & Supplies |
| Industry Key |
medical-instruments-supplies |
| Ipo Expected Date |
2,025-02-19 |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany. |
| Long Name |
Anbio Biotechnology |
| Market |
us_market |
| Market Cap |
417,405,312 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_1914568067 |
| Most Recent Quarter |
1,767,139,200 |
| Net Income To Common |
6,403,463 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
437,595,264 |
| Open |
9.78 |
| Operating Cashflow |
-6,739,075 |
| Operating Margins |
0.59093 |
| Payout Ratio |
0.0 |
| Phone |
49 698 7003 9170 |
| Previous Close |
9.97 |
| Price Hint |
2 |
| Price To Book |
13.842795 |
| Price To Sales Trailing12 Months |
48.27256 |
| Profit Margins |
0.74055 |
| Quick Ratio |
177.127 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.46000004 |
| Regular Market Change Percent |
-4.6138415 |
| Regular Market Day High |
9.78 |
| Regular Market Day Low |
9.0 |
| Regular Market Day Range |
9.0 - 9.78 |
| Regular Market Open |
9.78 |
| Regular Market Previous Close |
9.97 |
| Regular Market Price |
9.51 |
| Regular Market Time |
1,784,059,200 |
| Regular Market Volume |
25,524 |
| Return On Assets |
0.14664 |
| Return On Equity |
0.27049 |
| Revenue Growth |
0.739 |
| Revenue Per Share |
0.198 |
| Sand P52 Week Change |
0.20365608 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
43,891,200 |
| Shares Percent Shares Out |
0.002 |
| Shares Short |
89,295 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
87,425 |
| Short Name |
Anbio Biotechnology |
| Short Percent Of Float |
0.002 |
| Short Ratio |
1.79 |
| Source Interval |
15 |
| Symbol |
NNNN |
| Total Cash |
11,901,231 |
| Total Cash Per Share |
0.271 |
| Total Debt |
0 |
| Total Revenue |
8,646,844 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
0.14 |
| Trailing P E |
67.92857 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
25.85055 |
| Two Hundred Day Average Change |
-16.34055 |
| Two Hundred Day Average Change Percent |
-0.63211614 |
| Type Disp |
Equity |
| Volume |
25,524 |
| Website |
https://www.anbiobiotechnology.com |
| Zip |
60,327 |